ipilimumab
bms
['melanoma', 'melsm', 'ipilimumab']
#esmo22 highlights on tumour-infiltrating lymphocytes versus ipilimumab in patients with #advancedmelanoma: the phase 3 study. #melsm #melanoma #medtwitter #onctwitter
The European Society for Medical Oncology (ESMO) is the leading organisation for cancer education and information, supporting the oncology community’s work.